Cargando…
Alteration of m6A RNA Methylation in Heart Failure With Preserved Ejection Fraction
Background: Heart failure with preserved ejection fraction (HFpEF) is a heterogeneous disease, in which its pathogenesis is very complex and far from defined. Here, we explored the N(6)-methyladenosine (m6A) RNA methylation alteration in patients with HFpEF and mouse model of HFpEF. Methods: In this...
Autores principales: | Zhang, Beijian, Xu, Yamei, Cui, Xiaotong, Jiang, Hao, Luo, Wei, Weng, Xinyu, Wang, Yun, Zhao, Yuhong, Sun, Aijun, Ge, Junbo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7973040/ https://www.ncbi.nlm.nih.gov/pubmed/33748197 http://dx.doi.org/10.3389/fcvm.2021.647806 |
Ejemplares similares
-
Microvascular Rarefaction and Heart Failure With Preserved Ejection Fraction
por: Zeng, Heng, et al.
Publicado: (2019) -
Interatrial Shunt Device for Heart Failure With Preserved Ejection Fraction
por: Kaye, David M., et al.
Publicado: (2019) -
Rationale for the Use of Pirfenidone in Heart Failure With Preserved Ejection Fraction
por: Graziani, Francesca, et al.
Publicado: (2021) -
Trends in cause‐specific readmissions in heart failure with preserved vs. reduced and mid‐range ejection fraction
por: Cui, Xiaotong, et al.
Publicado: (2020) -
Weight Change and Mortality Risk in Heart Failure With Preserved Ejection Fraction
por: Huang, Peisen, et al.
Publicado: (2021)